Behavioral toxicology of solvents.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 411, doi. 10.1002/ddr.430200402
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 1990 AND VI 20 AND IP 4
Results: 7
1
2
Evidence for an action of heptaminol hydrochloride (Hept-a-myl<sup>R</sup>) on the central nervous system based on an increase in intracranial self-stimulation behavior in the mouse.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 465, doi. 10.1002/ddr.430200406
- By:
- Publication type:
- Article
3
Masthead.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. fmi, doi. 10.1002/ddr.430200401
- Publication type:
- Article
4
Prophylactic effects of novel dihydropyrazolopyridine (83-0256) and dihydrothienopyridine (83-0312, 83-0327) calcium antagonists in stroke-prone spontaneously hypertensive rats.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 453, doi. 10.1002/ddr.430200405
- By:
- Publication type:
- Article
5
The role of beta-endorphin and related peptides in the pathogenesis and treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 445, doi. 10.1002/ddr.430200404
- By:
- Publication type:
- Article
6
NPC 205 is a potent and selective adenosine A<sub>1</sub>, receptor antagonist: Correlation among receptor binding, biochemical, and physiological assays.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 429, doi. 10.1002/ddr.430200403
- By:
- Publication type:
- Article
7
Does AAMI constitute a real disease entity? A placebo-controlled double-blind study with sabeluzole (R58 735) in a patient population with real memory problems.
- Published in:
- Drug Development Research, 1990, v. 20, n. 4, p. 473, doi. 10.1002/ddr.430200407
- By:
- Publication type:
- Article